Lazard Acquiring Campbell Lutyens: Our Thoughts on a Defining Deal

What the acquisition means for the private capital advisory market, for GPs, and for the LPs who rely on independent advice

Executive Summary

Lazard’s acquisition of Campbell Lutyens is the most significant transaction in the private capital advisory market in a generation. It is a serious, strategically coherent move that reflects something real about where the private markets are heading, and it deserves to be assessed on those terms rather than treated as routine consolidation.

The deal brings together two businesses with genuinely complementary strengths: Lazard’s depth in M&A, restructuring, and financial sponsor relationships; and Campbell Lutyens’ expertise in fund placement, secondary advisory, and GP capital solutions. The combined platform, operating as Lazard CL, will be able to advise clients across a broader range of situations than either firm could address independently.

Our view is that the strategic logic is sound but the execution challenge is real, and that the deal has implications for LPs that deserve careful thought. The emergence of a fully integrated advisory platform at this scale changes the competitive landscape for independent advisers, raises questions about conflicts of interest that the industry will need to work through, and reflects a structural shift in how GPs are thinking about the relationship between fundraising, liquidity, and strategic optionality.